We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Technology Bridges Gap Between New Genome Data and Years of Research

By LabMedica International staff writers
Posted on 10 Sep 2009
Since the initiation of the Human Genome Project, an explosion of data has sent the science world scurrying. More...
There is a growing demand to customize genomic codes, which inventory the "ingredients for life,” but do not sufficiently clarify how those ingredients function.

A Rutgers University-Camden (NJ, USA) biochemist is addressing this knowledge gap through the creation of a database for quick "background checks” on all known enzyme functions. Because of a U.S. National Institute of Health (Bethesda, MD, USA) grant, Dr. Peter Palenchar, an assistant professor of chemistry at the University of Rutgers-Camden (NJ, USA; ), will categorize decades-worth of research on enzymes into a database, starting with those that bind to molecules that contain adenosine.

The US$200,000 grant will allow Dr. Palenchar to track and simplify what has been written about some 130 enzymes, including energy-creators adenosine triphosphate (ATP) and adenosine diphosphate (ADP). "There are 50-plus years of good data on how enzymes function, but it's a tedious process to understand the specialized language used in enzymology papers. Question is: how do you access that information quickly?” stated Dr. Palenchar. His goal is to create a standard vocabulary to describe how enzymes function for the biomedical community, particularly those who work with anticancer drugs that target enzymes. Dr. Palenchar, with assistance from Rutgers-Camden undergraduate Jason Cargill and graduate student Salvador Gomez, will not only establish this new vocabulary for an accessible database, but also assess its effectiveness in determining the accuracy of genomic codes.

To do this, the Rutgers-Camden research team will compare the genomic sequencing in two organisms that contain "functionally important” amino acids: Arabidopsis thaliana, a plant commonly known as thale cress, and Plasmodium falciparum, the pathogen that causes malaria. "There could be good evidence that these enzymes are doing something different,” noted the biochemist, who has published his research in the past in the journal Genome Biology.

According to Mr. Gomez, who is searching primary publications through online databases such as PubMed and Academic Search Premier, this research is important. "This research has given me an opportunity to do meaningful work at a higher level,” he noted. "Knowing my work will be utilized by other scientists is a great feeling.”

Dr. Palenchar has been studying enzymes for the past 10 years. He teaches biochemistry at Rutgers-Camden.

Related Links:

Rutgers University-Camden



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Portable POCT Blood Gas Analyzer
BD100
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: The method combines metagenomic sequencing with computational filtering to identify likely disease-causing bacteria and viruses (Image Credit: iStock)

Computational Filters Enhance Metagenomic Detection of Meningitis and Encephalitis

Infections of the central nervous system, such as meningitis and encephalitis, can be severe and require prompt diagnosis and treatment. Clinicians typically evaluate cerebrospinal fluid alongside symptoms... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.